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Abstract 
Glaucoma is the second leading cause of blindness and affects over 70 million people worldwide. 
Intraocular pressure (IOP), a well-established risk factor for primary open angle glaucoma, the most 
common form of glaucoma, is primarily regulated by aqueous humor outflow through drainage tissues, 
specifically the trabecular meshwork (TM). In primary open angle glaucoma, TM cellularity is 
significantly decreased in comparison to age-matched healthy eyes, presumably limiting the TM’s ability 
to regulate IOP. It is hypothesized that regenerating TM cellularity in a glaucomatous eye would lead to 
proper IOP and aqueous outflow regulation, preventing further vision loss associated with glaucoma. 
Towards this, we investigated the use of TM cell-derived exosomes, small secreted particles 40nm-1μm 
in diameter, to induce differentiation in adipose-derived mesenchymal stem cells (MSC) toward a TM 
lineage. Using established TM characterization and exosome isolation methods, we co-cultured TM-
derived exosomes and MSCs, along with control TM and MSC cells, for two weeks and observed changes 
relative to untreated MSCs and TM cells. While experimental groups were not significantly different from 
untreated MSC cells, trends relating exosome concentration and TM phenotype were observed. 
Importantly, untreated TM cells were found to be significantly different from past research in three out of 
four characterization assays, indicating phenotypic loss during cell culture without exosome treatment. 
These results highlight the importance of culture conditions necessary to attain and maintain the TM 
phenotype.  Further, trends from this study support the idea that exosomes play a role in TM differentiation 
and inform efforts to develop glaucomatous, stem cell-based regenerative therapeutics.  
 
Introduction 
Glaucoma, the second leading cause of blindness, affects over 70 million people worldwide, and 
its incidence is expected to continue to rise with an aging population1. Intraocular pressure (IOP), a well-
established risk factor for glaucoma, is primarily regulated by aqueous humor outflow through the 
drainage tissues in the anterior eye, specifically the trabecular meshwork (TM)2. In primary open angle 
glaucoma, TM cellularity is significantly decreased in comparison to age-matched healthy eyes, 
presumably limiting the TM’s ability to regulate IOP3. It is hypothesized that regenerating TM cellularity 
in a glaucoma-affected eye would lead to proper IOP and outflow regulation.  
Stem cells are undifferentiated cells capable of differentiating into other cell types. Stem cells have 
become more and more popular for regenerative medicine, since their first use in hematopoietic stem cell 
transplants for treating radiation damage4. In 1998, human stem cells were derived from embryos, 
contributing both scientific understanding of how human tissues form and regenerate5 but raising ethical 
questions about their use, as the embryo was destroyed during the procedure. To avoid these ethical 
complications, Takahashi et al. developed a process to create induced pluripotent stem cells (iPSCs), adult 
cells reprogrammed to an embryonic-like stem cell state6. While iPSCs can avoid immune rejection and 
ethical hurdles, they still pose risk of teratoma tumor formation and require costly, lengthy reprogramming 
methods which are difficult to translate clinically. Alternatively, adipose-derived stem cells have been 
proposed as an effective source of tissue regeneration, capable of differentiating into multiple cell types 
while being widely available from liposuction procedures7. Recently, we have been able to characterize 
differences between adipose-derived mesenchymal stem cells (MSCs) and TM cells as a first step towards 
using adipose-derived stem cells for TM regeneration8. Furthermore, preliminary results show evidence 
that MSCs can differentiate through co-culture with TM cells; however, only a low efficiency, inconsistent 
degree of differentiation was reached9. Interestingly, stem cells treated with TM-derived conditioned 
media seemed to express further and more consistent differentiation, further justifying this study. For these 
reasons, we investigated effects of adding endogenous agents to the culture medium to more consistently 
induce MSCs to differentiate into phenotypical and functional TM cells. Exosomes—cell-borne 
membrane-bound particles ranging from 40 to 1 μm10—represent a potentially effective approach for stem 
cell differentiation since they are inexpensive, readily available, and simple to use. Here, we explore their 
application for TM differentiation. 
Literature Review 
Glaucoma and Trabecular Meshwork 
Currently, medical and surgical glaucoma treatments focus on decreasing intraocular pressure (IOP) as 
their primary goal11. IOP is related to flow of aqueous humor (AH), a clear fluid produced by the ciliary 
processes to provide nutrients to avascular tissues in the anterior chamber. Importantly, elevated IOP is a 
well-established risk factor for glaucoma, and production rate of AH remains approximately constant 
throughout glaucoma progression12-14. Therefore, elevated IOP is primarily a result of poor AH outflow, 
regulated by the drainage tissues of the anterior chamber, specifically the trabecular meshwork (TM)2. 
The TM regulates IOP by modulating AH outflow to the circulatory system15, and actively ‘cleans’ debris 
from exiting AH through phagocytosis16. In 1981, a study of 35 subjects, ranging in age from birth to 81 
years of age, found that in primary open angle glaucoma, TM cellularity is significantly decreased in 
comparison to age-matched healthy eyes3. Decreased cellularity is theorized to inhibit the TM’s ability to 
regulate IOP, and given this reduced TM cellularity and strong connection to IOP regulation, it is believed 
that recellularizing the TM in a glaucoma-affected eye would lead to proper IOP and outflow regulation, 
and reduction in glaucoma-associated symptoms. 
Paracrine Signaling and Exosomes 
Paracrine signaling is one of many categorizations of intercellular communication. Unlike 
endocrine signaling, the long-distance and slow communication between tissues and cells of the body, 
paracrine signaling takes place between close or adjacent cells. A proposed major vehicle for paracrine 
signaling is exosomes: Exosomes are small (40-100nm) collections of proteins and  other source-cell 
dependent material encased in a lipid bilayer membrane, released either when multivesicular bodies 
combine with plasma membrane or by pinching off directly from the plasma membrane17. Exosomes were 
first observed in 1983 when Pan et al. and Harding et al. described small (~50nm) vesicles ejected from 
blood reticulocytes18, 19, although the term ‘exosomes’ did not appear until a few years later when Rose 
Johnstone coined the term20. The mRNA and microRNA cargo of exosomes was first analyzed in 2007, 
revealing not only differences in mRNA and microRNA from those found in cells, but also that the mRNA 
is fully functional21. Exosomes are secreted from most, if not all, cell types, and have been implicated in 
bodily processes such as immune suppression, inflammation, genetic information encoding, waste 
management, and coagulation22. 
Regenerative Medicine 
Exosomes are understood to play a significant role in stem cell differentiation22. One study 
investigated the possibilities of exosome-induced differentiation for bone regeneration, stating the results 
“show the potential of cell derived exosomes in bone regenerative medicine and opens up new avenues 
for future research23.” Furthermore, researchers have also used exosomes as paracrine signals to 
differentiate stem cells into cardiomyocytes, with treated cells beginning to beat with cardiac rhythm24.  
Focusing on regenerating the trabecular meshwork, several studies have shown potential for stem 
cell tissue regeneration therapies. In a very recent study, induced pluripotent stem cells (iPSCs) 
differentiated to a TM lineage were delivered into the TM in vivo in mice. Over a 9 week period, the 
treatment restored phenotypical TM function, regulating IOP and preventing retinal ganglion cell axonal 
loss25. While promising, iPSCs for TM regeneration are challenging from a clinical translation standpoint 
due to complex reprogramming and tumorigenic potential. Alternatively, multipotent stem cells isolated 
from the TM tissue have also been differentiated to TM cells through application of aqueous humor, 
though the differentiated cells were functionally characterized by only their phagocytic properties26. 
Adipose-derived stem cells  have been reviewed and proposed as an effective source of tissue regeneration, 
capable of differentiating into multiple cell types while being widely available from liposuction 
procedures7. Recently, we have characterized differences between adipose-derived mesenchymal stem 
cells (MSCs) and TM cells, specifically examining differences in myocilin expression after exposure to 
dexamethasone, cell markers, contractile properties, and phagocytic behavior8. TM cells have been shown 
by Stamer et al. to secrete exosomes with a protein profile containing common exosome markers like CD-
9 and CD-63, as well as TM-specific proteins like emilin-1 and myocilin27. Given the potential for 
exosome-driven differentiation towards a TM lineage and the accessibility of the exosomes themselves, a 
method for differentiating widely available MSCs into TM cells using only exosome-mediated signaling 
would represent an more economical and effective treatment option for regenerating the TM cellularity of 
glaucoma-affected eyes.  
This project investigated the application of exosomes from TM cells as a mechanism to achieve 
MSC to TM lineage differentiation, expanding knowledge about exosomes, the TM, and glaucoma 
treatment options.  
Methods and Materials 
Cell Sourcing and Culture 
Human TM cells were isolated and characterized by researchers at Duke University 
(acknowledgments to Dr. Daniel Stamer). For collecting conditioned media, TM cells were cultured and 
passaged in T-75 flasks (Falcon) in 1% exosome-free FBS (SystemBio), 1g/L glucose Alpha MEM 
medium (EFM). TM cells were allowed to adhere overnight and media was replaced every 2-3 days with 
fresh nano-clean EFM until cells were prepared for experiment.. Adipose-derived mesenchymal stem cells 
(Lonza), were characterized and cultured in T-75 flasks (Falcon) in 20% FBS (Corning), 4.5g/L glucose 
Alpha MEM medium for 1 day, then washed and replenished with 20% FBS, 4.5g/L glucose media every 
5 days until cells were prepared for experiment.  
Exosome Isolation and Characterization 
After culturing for two to three days, conditioned media from hTM cells was collected and 
transported on ice to undergo ultracentrifuge exosome isolation, following established methods28. Briefly, 
conditioned media was centrifuged at 2,000g (Sorval ST8R Centrifuge, ThermoFisher Scientific) for 20 
minutes to remove cells. The supernatant was then centrifuged at 10,000g for 30 minutes to remove cell 
debris. The supernatant was then transferred to polycarbonate aluminum ultracentrifuge bottles (Beckman 
Coulter) and centrifuged at 100,000g for 70 minutes with the Allegra X-15R Ultracentrifuge (Beckman 
Coulter). The supernatant was drawn, leaving 1mL at bottom containing the invisible exosome pellet. 
exosome pellet was then resuspended in PBS and centrifuged at 100,000g for 70 minutes again. 
Supernatant was aspirated, and exosome pellet was collected and resuspended in PBS and a protease 
inhibitor cocktail (Thermo-Scientific #78430) at -80ºC until analysis or application to stem cell cultures. 
Fresh reagents were used throughout.  
Size and concentration of particles in the isolated pellets were measured with nanoparticle tracking 
analysis (NTA) using ZetaView PMX 110 (Particle Metrix) and ZetaView Version 8.02.28 
(acknowledgments to Yutao Liu at the University of Augusta) Isolated pellet samples were diluted with 
PBS (Life Technologies) per manufacturer’s specifications prior to NTA. After calibrating with 100nm 
polystyrene particles, NTA measurements were recorded and analyzed at 11 positions with the ZetaView 
system, maintaining a  temperature between 22°C and 23°C. Zeta potential was measured using 0.05X 
PBS to adjust conductivity to near 500 µS/cm29. 
Differentiation Experiments 
Using established exosome isolation methods, conditioned media from cultured TM cells was 
separated into exosome isolates and leftover decanted media, including all the constituents of conditioned 
media except exosomes. Here, we called the leftover media conditioned media supernatant (CMS). At 
90% confluency, MSCs were passaged to 24 well plates at 5,000 cells/cm2. MSCs were split into six 
groups and treated with corresponding media: Only EFM; 1X concentration exosomes with CMS; CMS 
only; and 1X, 2X, and 4X exosome concentration in PBS (See Table 1).  TM cells, upon 90% confluency, 
were also passaged to 24 well plates at 5,000 cells/cm2 and treated with EFM only. Media was replaced 
every three to five days. Cells were treated for 2 weeks, followed by differentiation assessment. 
Differentiation Assays  
We have previously determined assays suitable for detecting differentiation from MSCs to TM cells8. 
Briefly, differentiation was evaluated through four assays: 
Dexamethasone Induction of Myocilin 
TM cells express myocilin in response to treatment with dexamethasone (DEX)30. Cells were 
cultured on 1% gelatin-coated glass coverslips in 24-well plate wells and treated with culture media for 7 
days, replacing media every three days. Cells were probed with 200 μg/mL MYOC goat antibody, then 
secondary donkey anti-goat Alexa Fluor 647, stained with DAPI and then imaged using a Leica DM^ 
Fluorescent Microscope with the 10X objective. Images of 3 replicate dexamethasone-induced samples 
and non-induced samples were analyzed for mean fluorescence intensity of myocilin and nuclei count 
(DAPI) using ImageJ. Ratios of myocilin fluorescent intensity and cell count were averaged for each 
dexamethasone treated experiment and compared to respective untreated controls 
Collagen Gel Contractility 
Calf skin Collagen I (MP Biomedical) was prepared (under sterile conditions) in 0.2% (v/v) acetic 
acid at a concentration of 6 mg/mL. The solution was gently agitated at 4oC for 1 to 2 days to ensure the 
collagen was completely dissolved. The collagen solution was then diluted to 3 mg/ml (0.1% acetic acid) 
with sterile H2O.   
Cells were counted, centrifuged, and resuspended in serum-free media at 900,000 cells/mL. 
Immediately prior to plating, the 3mg/ml collagen was neutralized with NaOH to a pH of 7.4, matching 
that of DMEM media. Cells in serum-free medium were resuspended in the neutralized collagen solution 
at a 2:1 cell/collagen ratio (600, 000 cells/ml) and plated in 96 well plates, 80 μL per well. Cultures were 
incubated 20 minutes at room temperature to allow the collagen to solidify into gels. 80 μL of serum-free 
media was added to each well and cultures were maintained in a humidified atmosphere, 37°C, 5% CO2. 
24 hours after seeding, a sterile pipette tip was used to release each gel from the walls of its well. Gels 
were imaged (ChemiDoc MP, Bio-Rad) 12 hours later. Images of any gels that did not release from the 
wells were discarded and not considered, as adherence forces interfered with contractile forces. Images 
obtained of the surface area of contracted gels and 96-well plate were compared and analyzed using 
ImageJ analysis software.   
Phagocytosis Assay 
Cells were seeded at 50,000 cells/cm2 onto 48 well plates in Hanks’ balanced salt solution (HBSS) 
supplemented with 5% FBS and 2mM L-glutamine31. After 24 hours, pHrodo green e.coli BioParticles 
(Life Technologies) were reconstituted in HBSS media as per the manufacturer’s protocol and added to 
cells. After a 4-hour incubation at 37ºC, cells were detached with 0.05% Trypsin/EDTA and cells were 
processed by flow cytometry for particle fluorescent intensity (100 µL/min Attune NxT, Thermo-
Scientific). 
Reverse Transcription Polymerase Chain Reaction Analysis 
RNA was isolated from samples using TRIzol reagent (Life Technologies) and further purified 
using Aurum Total RNA Mini Kit (Bio-Rad), per the manufacturer’s protocol. RNA concentration and 
purity were determined using a Nanodrop 2000C spectrophotometer (Thermo-Scientific). Reverse 
transcription to clonal DNA (cDNA) was performed on 1μg RNA samples per the manufacturer’s protocol 
(Bio-Rad). cDNA samples were analyzed against seven primer pairs (Supplementary Table 1) (Du et al., 
2012, Spandidos et al., 2008, Spandidos et al., 2010, Wang and Seed, 2003, Ye et al., 2012). SYBR green 
reagent (Bio-Rad) was used to quantify DNA amplification in real time throughout the PCR cycle 
(StepOne Plus Real Time PCR System, Applied Biosystems). The resulting cyclic threshold (CT) values 
were normalized to the geometric mean of three reference genes (GUSB, YWHAZ, and TATA BP; see 
Table 2) and further normalized against untreated MSC samples using the 2-ΔΔCT methodology (Livak and 
Schmittgen, 2001). 
Results 
Exosome Isolation and Analysis 
Exosome isolates from conditioned media, ranging from 60μL to 80μL, were analyzed for particles 
between 7 and 615 nm by NTA (n = 10). Median particle diameter ranged from 113 and 140 nm (Figure 
1). Particle concentrations ranged from 4.4 to 29.6 million particles per cm3, with a mean of 18.5 million 
particles per cm3 (Figure 2). These median particle diameter and concentration fall within reasonable 
ranges for that of exosomes. 
Differentiation Assays 
Dexamethasone Induction of Myocilin 
Cell nuclei were stained with DAPI and myocilin was immunolabeled. Mean myocilin 
fluorescence varied across experimental groups with dexamethasone treatment. Average fluorescence 
among TM, 2X, and 1X groups more than quadrupled that of MSC, CMS, ExoCMS, and 4X. After 1 week 
dexamethasone treatment, no groups changed significantly except for CMS, increasing by about 160%. 
However, this percentile increase may be explained by its already-low fluorescence for both 
dexamethasone-induction and untreated groups (Figure 3). Example images of TM, 4X, and MSC sample 
groups can also be found in Image 1.  
Contractility 
Pictures taken 12 hours after gel release were analyzed. Experimental gels which failed to detach 
from the 96-well walls were not included in analysis, as adhesion forces on the wall interfere with the 
contractile forces and cannot be compared to wells where full detachment occurred. Area, as a percentage 
of the total well area, can be visualized in Figure 4. No sample group, including TM controls, could be 
proven significantly different in area from MSC controls, on average: See Table 2 for % well area and p-
values. However, trends suggest changes in area that correlate with exosome concentration: lessening 
contractility and more TM-characteristic contractile behavior with higher exosome concentration. Results 
also allude to a synergistic effect of exosomes and EFM, which combined to achieve a stronger effect.  
Phagocytosis 
For assessing phagocytosis, cell samples were incubated with fluorescent phagocytic particles for 
4 hours before fluorescent intensity was measured by flow cytometry. Fluorescence in samples not given 
phagocytosis particles consistently held between 950 and 1060 (arbitrary units, AU) in value. Samples 
given phagocytic particles ranged from 7500 to 29000 (AU) in value.  
Untreated MSCs expressed the highest fluorescent intensity, with 28,773 (AU). Sample groups 
were not significantly different from each other, as a result of high variability within each sample group. 
However, averaged median fluorescence among each experimental group rested below that of TM control 
samples, which were much lower than that of the MSC control samples. Median fluorescence trended 
towards TM behavior across all experimental groups, though again not statistically significant. 
Fluorescence values in sample groups given particles can be visualized in Figure 5. 
RT-PCR Protein Quantification 
To compare and quantify experimental groups, transcript expression CT results for the five 
differentiation-associated genes (tPA, Mucin 1, CHI3L1, MGP, and MYOC) were first normalized to the 
geometric mean of three reference genes, generating ΔCT values. These ΔCT values were then compared to 
all other groups, including that of the MSC controls for each gene. To avoid cross-comparing different 
plates, normalization calculations were derived from and applied to wells of the same plate. The MSC 
sample’s Muc1 expression immediately reached threshold, indicating a possible error in analysis. Each 
sample’s gene expression can be viewed in Table 3, and visualized in Figure 6. Through Tukey’s Multiple 
Comparisons Test, no significant differences could be established between any sample groups in all genes 
except myocilin. Within Myocilin, a few groups differed significantly: TM and 1X groups (p=0.0068), 
MSC and 1X groups (p=0.0079), CMS and 1X groups (p=0.0219), ExoCMS and 1X groups (p=0.0067), 
4X and 1X groups (p=0.0073), and 2X and 1X groups (p=0.0091). From this, 1X concentration exosome 
group shows a significant departure from all the other groups, though it departs from both TM and MSC 
control groups.  
Discussion 
Exosomes may represent a novel approach for understanding the development of trabecular 
meshwork cells and restoring lost trabecular meshwork functionality in primary open angle glaucoma. 
Utilizing established characterization and exosome isolation methods, we explored functional and 
characteristic changes in MSC’s treated with exosomes with a goal of understanding the role of exosomes 
in developing stem cells towards a TM lineage. If differentiation towards a TM lineage with MSC’s using 
exosomes can be shown possible, exosomes may play a large role in accelerating TM regeneration 
therapies and better understanding embryological development of TM tissue.  
First, we established that exosomes can be isolated from TM cells (See Figure 1 and 2) and these 
particles’ median diameter was similar to exosomes, around 130nm. There is no evidence the exosomes 
were improperly manipulated between isolation steps and differentiation experiments, but potential 
evidence was not necessarily observable, because analysis of media at transfer steps would destroy the 
sample. There is also no evidence that freezing the exosomes for storage were damaging the cells, as 
exosomes were analyzed after freezing, and freezing at -80º C is routinely performed for exosome storage.  
Control Groups Analysis 
Interestingly, in many experiments the TM samples were not significantly different from MSC 
controls. This can be explained by a few general conditions. The first possibility is these experiments or 
tests are not accurately tracking differences between TM cells and MSCs. This seems unlikely, however, 
given the body of work demonstrating clear and significant differences that formed the backbone of this 
project8, 32, 33. Second, it’s possible the experiments themselves may not have been executed correctly, 
resulting in null results. It’s not entirely clear that this is the case, though, as the samples were otherwise 
without disqualifying problems, and most are common protocols run by investigators many times 
correctly. A third possibility is the TM and MSC cells used were unhealthy or otherwise abnormal, 
compared to average or typical TM and MSC cells or at the very least, compared to those in research 
characterizing differences between MSC and TM cells. To investigate, we obtained datasets from previous 
characterization analysis32, 34 and compared results from each TM and MSC pair. Some methods used in 
past characterization work differed slightly from methods in this work, though we believe a comparison 
is both possible and reasonable. 
Dexamethasone Induction of Myocilin 
Methods for gathering dexamethasone expression differed from characterization work: Past 
characterization work utilized western blotting and fluorescent flow cytometry, while we used fluorescent 
image analysis to retain cell counts. To analyze, we will be using only fluorescent flow cytometry, because 
both fluorescent flow cytometry and image analysis measured antibody fluorescence per cell, which can 
be compared. Average median fluorescence of each group was compared with its’ groups twin: MSC 
groups could not be shown to be significantly different (p=0.3826). TM groups, however, were 
significantly different with p-value of 0.0462 (Figure 7).  
Contractility Assay 
Contractility assay methods were retained from previous characterization work. However, 
contractility, as a percentage of area filled by cell gels, was not directly documented at 12 hours in past 
research. To provide a 12-hour data point, we extracted a linear regression using log of hours from past 
research data points and extrapolated a t=12 hours well area with 95% confidence intervals for analysis 
(Figure 8). The t=12 hours interpolated points were compared with our data (Figure 9). With Sidak’s 
Multiple comparisons test, we observed significant differences in the TM groups (p<0.0001), but no 
significant difference in the two MSC groups (p=0.7502). 
Phagocytosis 
Methods for phagocytosis assay were retained from previous characterization work, though 
variance among experiments should always be considered. Average fluorescence was compared using a 
student’s T-test. MSC groups for past work and ours was not shown to be significantly different: 25,801.0 
against 24,898.2 with a p-value of p= 0.077. However, TM group’s phagocytic activity differed 
significantly: 13,869.0 against 42,375.8 with a p-value of p< 0.0001 (Figure 10).  
RT-PCR Protein Quantification 
RT-PCR protocol was similar to previous characterization results. Genetic expression of each gene 
after normalizing to housekeeping was compared with student’s t test. Mean expression of any genes 
between the two MSC and two TM groups could not be shown significantly different from each other: p-
values were as high as 0.99 (Figure 11). 
As we compare this study’s TM and MSC groups to past research, we see no strong differences 
between the MSC groups, but TM groups differ significantly, across three of the four characterization 
assays and accounting for intra-experimental variance.  Our TM control samples were not similar to those 
in past characterization research8. Though our TM and MSC cells were characterized by their sources, 
including multiple cell lines would have helped clarify any sourcing or cell line abnormalities, and we 
hope to include multiple cell lines in future research.  
Under the assumptions of a typical cell line and source, the experiments having sufficient power 
in distinguishing the two cell types, and the experiments been run correctly, a change must have occurred 
in the TM cells away from normality during the experiment. Characteristic cells grown in cultures 
dissimilar to their natural conditions can lose characteristics35, 36. Important physiological and 
environmental factors not present in vivo, but likely present here, include nutrient-rich media, two-
dimensional culture, high passage number, and hard culture flask surface. The TM, neighboring 
Schlemm’s canal at the limbus or cornea-sclera margin, is avascular which of course differs from cell 
culture media in nutrient and oxygen content. 
Experimental Groups 
No experimental group showed consistent statistical differences from MSC samples in most 
characterization assays. That’s not to say nothing can be said: Trends in many assays suggest samples 
given exosomes tracked similar results as this work’s TM cells, including Phagocytosis, Contractility, and 
especially RT-PCR. With the presence of exosomes, MSCs seem to trend towards TM characteristics. We 
believe steps could be taken in future research to improve the power of these experiments, including: 
Larger cell sample sizes, as many cells were removed during steps in characterization assays, and more 
powerful statistical analysis methods for highly variable results like RT-PCR data. 
Conclusion 
If TM control groups in this study lost their characteristic traits in culture, these results cannot 
inform the possibilities of exosomes for MSC differentiation to TM phenotype. Though development of 
MSC-to-TM differentiation through application of exosomes and its implications for novel treatment 
options and understanding remain a possibility, this study presents a circumstance in TM research that 
threatens past and future research. Namely, culturing TM cell lines in culture similar to that of this study 
may encourage changes in TM cells away from a recognizably TM lineage. We propose further research 
to investigate characteristic changes in TM as a result of common culturing practices, to both justify 
research using cultured TM cells and better learn about TM behavior and response in varying 
environments. 
Tables and Figures 
 Group Name Description 
1 MSC Control or “MSC” EFM only 
 TM Control or “TM” EFM only 
2 1X Concentration exosomes with CMS or “ExoCMS” 1X Concentration exosomes added to CMS 
3 4X Concentration exosomes or “4X” EFM and 4 Million Particles/mL added to EFM 
4 2X Concentration exosomes or “2X” EFM and 2 Million Particles/mL added to EFM 
5 1X Concentration exosomes or “1X” EFM and 1 Million Particles/mL added to EFM 
6 Conditioned Media Supernatant or “CMS” Exosome-depleted conditioned media only 
Table 1: Sample group names and description of treatment media. Two controls, representing both cell 















Primer Name Category Primer Sequence (5’ to 3’) Reference 












Tissue Plasminogen Activator (tPA) 
Forward AGCGAGCCAAGGTGTTTCAA PrimerBank 
















285026518c137, 38 Reverse CTGCGGTACAATCCCAGAACT 
Tyrosine 3/tryptophan 5-




208973243c126 Reverse GACCTACGGGCTCCTACAACA 
Beta-Glucuronidase (GUSB) 
Forward GTCTGCGGCATTTTGTCGG Primer-BLAST 
[36] Reverse CACACGATGGCATAGGAATGG 
Table 2: Primer sequences for RT-PCR gene expression assay. References indicate motivation for each 







Figure 1: Histogram plot of particle size distribution from ten 80μL isolates from TM cells after 
ultracentrifugation steps. Median particle diameter consistently rests at 135nm, similar to most EVs. 
 
Figure 2: Mean particle concentration from ten 80μL TM cell sample isolates, in million particles per 


















Sample A (median = 135.00 nm)
Sample B (median = 139.13 nm)
Sample C (median = 135.00 nm)
Sample D (median = 135.00 nm)
Sample E (median  = 135.00 nm)
Sample F (median = 135.00 nm)
Sample G (median = 135.00 nm)
Sample H (median = 129.84 nm)
Sample I (median = 135.00 nm)

























Figure 3: Myocilin expression as represented by antibody fluorescent stain after treating with 
dexamethasone for a week. Error bars represent standard deviation. Fluorescence values here are 
normalized from baseline fluoresence taken from cells not given dexamethasone. ExoCMS and 1X 




Image 1: Example images of myocilin expression after staining with MYOC antibodies. Three groups 
are shown, left to right: TM control (A), 4X Exosomes (B), and MSC control (C).  
 
Group Mean % of Well Area p-Value (Against MSC samples) 
TM 8.765% (n=5) 0.469 
MSC 7.412% (n=6) --- 
CMS 4.051% (n=2) 0.169 
ExoCMS 8.959% (n=3) 0.468 
4X 6.876% (n=4) 0.314 
2X 5.757% (n=4) 0.250 
1X 5.144% (n=1) Sample Size too low 
Table 2: Percentage of well after 12 hours in contractility gel, as well as p-values from heteroscedastic 
t-test against MSC samples. No group’s change in area was significantly different than MSC group’s 
response. 
 
Figure 4: Area of contractile gels after 12 hours, as a percentage of 96-well area. Inclusion of EVs in 
experimental cells trends with less contraction. No groups statistically different from any other. 
 
 
Figure 5: Mean fluorescence in samples given phagocytic particles normalized from cells not given 
phagocytic particle. Cells not given phagocytic particles had very similar fluorescence values (±110). 
Experimental groups tracked closely to TM control response, though variability in all samples prevented 
statements of statistical significance. 
 
 
TM CMS ExoCMS 4X 2X 1X 
CHI3L1 683.0 ± 1173.9 123.5 ± 178.9 95.3 ± 26.4 11.5 ± 8.3 13.1 ± 14.5 53.5 ± 89.1 
MGP 46.8 ± 80.8 3.4 ± 5.7 3.9 ± 3.4 4.4 ± 4.6 4.5 ± 7.7 26.8 ± 46.3 
tPA 1.0 ± 1.0 2.9 ± 4.8 1.8 ± 1.3 2.7 ± 2.9 1.4 ± 1.7 1.0 ± 1.6 
MYOC 71.1 ± 116.4 12.1 ± 11.1 8.8 ± 8.6 5.4 ± 5.0 4.5 ± 7.6 0.1 ± 0.1 
MUC 1 1.2 ± 1.7 7.0 ± 12.0 8.3 ± 7.3 0.8 ± 0.7 1.8 ± 3.1 0.0 ± 0.1 
Table 3: Fold change in expression, relative to MSC samples. All samples normalized against 
housekeeping genes TATA Binding Protein, YWHAZ, and GUSB.  
 
Figure 6: Fold-change in expression of TM and MSC marker genes in each experimental group. Most 
groups follow TM cell trends. Specifically, cells treated with EV’s and media (ExoCMS group) tracked 
TM myocilin expression well, indicating trends in behavior. 
 
Figure 7: Dexamethasone-induced myocilin expression, as assessed by fluorescent antibodies, in this 
work’s control TM and MSC cells and that of Snider et al. Expression in the two MSC groups did not 
significantly differ (p=0.3826), while TM cells were shown to be significantly different (p=0.0462). 
 
Figure 8: Interpolation of results from Snider et al. Percentage of well area at 12 hours was interpolated 
with 95% confidence for later comparison to this work.  
 
Figure 6: Comparison of contractile response, as percentage of well area after 12 hours, in this work’s 
control TM and MSC and past literature. Past work’s 12 hour response was interpolated with 95% 
Confidence. This work’s MSC control’s response could not be shown significantly different.  
 
Figure 3: Phagocytic activity, as assessed by Fluorescently tagged E. coli, of two-week cultured cells 
against fresh, taken from Snider et al.’s work. TM cells differed much more than MSC’s, indicating a 
susceptibility to loss in characteristics. 
 
Figure 4: Comparison of TM and MSC RT_PCR cycles, normalized to housekeeping genes, from this 
work, after culturing through experiment, and past literature. No expression for both cell types were 
significantly different from each other. 
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